|1.||Tanaka, Katsuaki: 10 articles (10/2015 - 03/2008)|
|2.||Morimoto, Manabu: 10 articles (10/2015 - 03/2008)|
|3.||Numata, Kazushi: 10 articles (10/2015 - 03/2008)|
|4.||Maruyama, Hitoshi: 8 articles (12/2015 - 02/2011)|
|5.||Yokosuka, Osamu: 8 articles (12/2015 - 02/2011)|
|6.||Takahashi, Masanori: 8 articles (12/2015 - 02/2011)|
|7.||Nozaki, Akito: 8 articles (10/2015 - 01/2009)|
|8.||Shimada, Taro: 7 articles (12/2015 - 03/2012)|
|9.||Kondo, Masaaki: 7 articles (10/2015 - 04/2009)|
|10.||Takebayashi, Shigeo: 6 articles (10/2015 - 03/2008)|
|1.||Hepatocellular Carcinoma (Hepatoma)
12/01/2015 - "The purpose of this study was to clarify the diagnostic value of contrast-enhanced ultrasonography (CEUS) with perflubutane in determining the histologic grade in hepatocellular carcinoma (HCC). "
12/01/2015 - "Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma."
09/01/2014 - "To clarify the diagnostic value of contrast-enhanced ultrasound (CEUS) with perflubutane in the macroscopic classification of small nodular hepatocellular carcinomas (HCCs). "
09/01/2014 - "Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas."
01/01/2014 - "Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma."
|2.||Neoplasm Metastasis (Metastasis)
06/01/2014 - "Contrast-enhanced intraoperative ultrasound (CE-IOUS) using perflubutane may identify such metastases. "
09/01/2012 - "Contrast-enhanced intraoperative ultrasonography using perfluorobutane microbubbles for the enumeration of colorectal liver metastases."
09/01/2010 - "This study was conducted to evaluate the diagnostic efficacy of contrast enhanced ultrasonography (CEUS) with perflubutane (Sonazoid) for hepatic metastasis and compared it with that of 18-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT). "
11/01/2011 - "Letter to the editor re: contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100)."
08/01/2011 - "Contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100)."
|3.||Drug Toxicity (Drug Safety)
|4.||Liver Diseases (Liver Disease)
01/01/2013 - "This study suggests that perflubutane microbubbles could result in a liver specific phase and provide valuable information for diagnosis and detection of focal liver lesions which may improve the efficiency of contrast-enhanced ultrasound in clinical diagnoses of liver diseases. "
01/01/2014 - "This prospective study included 87 PIELs on contrast-enhanced sonograms (postvascular-phase: 10 min post-injection of perflubutane microbubbles) in 72 patients with chronic liver diseases (45 males and 27 females; age 65.0 ± 10.8y; PIEL diameter 12.5 ± 4.2 mm). "
03/01/2012 - "Intensity analysis was conducted on early-phase and late-phase (60 s and 900 s post-injection; perflubutane microbubble) harmonic sonograms in 33 focal hepatic lesions (≤ 15 mm; 30 patients with chronic liver disease) that were histologically proven as wHCC or RN. "
10/01/2015 - "Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease."
03/01/2015 - "To determine the usefulness of contrast-enhanced sonography using the perfluorobutane contrast agent Sonazoid (Daiichi-Sankyo, Tokyo, Japan) for establishing the diagnosis and cellular differentiation of hepatocellular carcinoma in patients with chronic liver disease. "
05/01/2012 - "Perflubutane-based ultrasound accurately predicts the grade of hepatic fibrosis. "
05/01/2012 - "To examine the feasibility of perflubutane-based ultrasound for grading hepatic fibrosis. "
09/01/2014 - "The aim of the study described here was to evaluate the significance of the hepatic filling rate of a perflubutane microbubble agent in predicting long-term outcomes and prognoses in 32 patients with cirrhosis (37-76 y, 20 females, Child-Pugh A16, B16). "
03/01/2015 - "This prospective study consisted of 91 subjects (63.0 ± 12.6 years, 30-86; 60 males, 31 females), 62 cirrhosis and 29 controls, who underwent both Doppler ultrasound and contrast-enhanced ultrasound with a perflubutane microbubble agent. "
11/01/2013 - "We determined the ability of contrast-enhanced ultrasound (CEUS) using perflubutane microbubbles to diagnose liver fibrosis and cirrhosis in rats using histology as the reference standard. "
|6.||Measles-Mumps-Rubella Vaccine (MMR Vaccine)
|7.||Yellow Fever Vaccine (Vaccine, Yellow Fever)
|8.||Succinic Acid (Succinate)
|10.||Interleukin-12 (IL 12)
|2.||High-Intensity Focused Ultrasound Ablation